CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial ResultsPRNewsWire • 12/01/22
CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative ColitisPRNewsWire • 11/15/22
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90PRNewsWire • 11/07/22
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17PRNewsWire • 11/03/22
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12PRNewsWire • 10/03/22
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, ItalyPRNewsWire • 09/19/22
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial ResultsPRNewsWire • 08/25/22
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine StudyPRNewsWire • 06/29/22
CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial ResultsPRNewsWire • 05/26/22
CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and ScreeningPRNewsWire • 04/25/22
CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial ResultsPRNewsWire • 03/24/22
CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologiesPRNewsWire • 02/16/22
CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery JournalPRNewsWire • 12/02/21
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial ResultsPRNewsWire • 11/18/21
CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and OrgansPRNewsWire • 11/15/21
CollPlant to Present at Dawson James Small Cap Growth Conference on October 21stPRNewsWire • 10/14/21
CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue ConstructsPRNewsWire • 10/11/21
CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021PRNewsWire • 09/30/21
CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 ConferencePRNewsWire • 09/27/21
CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)PRNewsWire • 09/09/21
CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in SeptemberPRNewsWire • 09/07/21